Newron Pharmaceuticals SpA Cash Flow-to-Debt Ratio
Newron Pharmaceuticals SpA cash flow-to-debt ratio. Newron Pharmaceuticals SpA (NWRN) has a Cash Flow-to-Debt Ratio of -0.03x as of December 2025, meaning its operating cash flow of CHF-1.33 Million could theoretically repay 0% of its total liabilities (CHF51.15 Million) in one year. Check NWRN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Newron Pharmaceuticals SpA (2005–2025)
Cash flow-to-debt ratio of Newron Pharmaceuticals SpA from 2005 to 2025. Historical debt coverage capacity for Newron Pharmaceuticals SpA across 21 annual periods. Check cash flow reinvestment rate of Newron Pharmaceuticals SpA to assess the company's total reinvestment commitment from operating cash flow.
Newron Pharmaceuticals SpA Cash Flow-to-Debt Ratio by Year (2005–2025)
Newron Pharmaceuticals SpA cash flow-to-debt ratio by year from 2005 to 2025. Year-by-year debt coverage analysis for Newron Pharmaceuticals SpA. For the full cash flow conversion analysis, see Newron Pharmaceuticals SpA operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.64x | CHF32.56 Million | CHF51.15 Million | ▲ +325.7% |
| 2024 | -0.28x | CHF-17.61 Million | CHF62.45 Million | ▼ -55.1% |
| 2023 | -0.18x | CHF-10.14 Million | CHF55.77 Million | ▲ +16.0% |
| 2022 | -0.22x | CHF-11.09 Million | CHF51.23 Million | ▲ +10.4% |
| 2021 | -0.24x | CHF-11.45 Million | CHF47.38 Million | ▲ +47.4% |
| 2020 | -0.46x | CHF-15.59 Million | CHF33.95 Million | ▲ +50.9% |
| 2019 | -0.94x | CHF-21.98 Million | CHF23.49 Million | ▲ +69.7% |
| 2018 | -3.09x | CHF-15.95 Million | CHF5.16 Million | ▼ -95.0% |
| 2017 | -1.58x | CHF-8.40 Million | CHF5.30 Million | ▲ +44.6% |
| 2016 | -2.86x | CHF-19.58 Million | CHF6.84 Million | ▼ -61.7% |
| 2015 | -1.77x | CHF-12.86 Million | CHF7.27 Million | ▼ -38.3% |
| 2014 | -1.28x | CHF-10.00 Million | CHF7.81 Million | ▼ -26.1% |
| 2013 | -1.02x | CHF-10.69 Million | CHF10.53 Million | ▼ -396.9% |
| 2012 | 0.34x | CHF5.83 Million | CHF17.04 Million | ▲ +148.3% |
| 2011 | -0.71x | CHF-4.94 Million | CHF6.98 Million | ▲ +74.3% |
| 2010 | -2.76x | CHF-19.13 Million | CHF6.94 Million | ▼ -48.1% |
| 2009 | -1.86x | CHF-23.06 Million | CHF12.39 Million | ▼ -37.5% |
| 2008 | -1.35x | CHF-19.93 Million | CHF14.73 Million | ▼ -26.6% |
| 2007 | -1.07x | CHF-13.87 Million | CHF12.97 Million | ▼ -103.2% |
| 2006 | -0.53x | CHF-9.63 Million | CHF18.30 Million | ▲ +76.2% |
| 2005 | -2.21x | CHF-14.33 Million | CHF6.48 Million | — |